2009
Diabetes Mellitus and Bone Disease in Cystic Fibrosis
Curran D, McArdle J, Talwalkar J. Diabetes Mellitus and Bone Disease in Cystic Fibrosis. Seminars In Respiratory And Critical Care Medicine 2009, 30: 514-530. PMID: 19760539, DOI: 10.1055/s-0029-1238910.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsDiabetes mellitusBone diseaseCystic fibrosisBone demineralizationCystic fibrosis-related diabetes mellitusCystic fibrosis-related diabetesType 2 diabetes mellitusType 2 diabetesLower body weightForms of diabetesHepatic glucose productionCystic fibrosis patientsGonadal dysfunctionPulmonary healthGlycemic excursionsChronic inflammationClinical entityLung diseaseInsulin sensitivityPancreatic insufficiencyMetabolic effectsIntestinal absorptionBody weightFibrosis patientsMellitus
2007
Macrolides in Cystic Fibrosis
McArdle JR, Talwalkar JS. Macrolides in Cystic Fibrosis. Clinics In Chest Medicine 2007, 28: 347-360. PMID: 17467553, DOI: 10.1016/j.ccm.2007.02.005.BooksConceptsCystic fibrosisChronic pulmonary diseaseDevelopment of bronchiectasisMajority of patientsProgressive lung diseasePositive therapeutic effectHost inflammatory responseAirway surface liquidChronic infection resultsAzithromycin administrationDiffuse panbronchiolitisPulmonary diseaseClinical benefitLung diseaseMucociliary clearanceInflammatory responseTherapeutic effectInfection resultsTissue damageViscous secretionsPatientsSurface liquidDiseaseFibrosisMacrolide antibiotics